Search results
AstraZeneca's (AZN) 3 Cancer Drugs Get CHMP Nod for Expanded Use
Zacks via Yahoo Finance· 1 year agoAstraZeneca AZN and partner Merck MRK announced that the Committee for Medicinal Products for Human...
FDA Delays Decision on AstraZeneca (AZN), Merck's Lynparza sNDA
Zacks via Yahoo Finance· 1 year agoThe FDA extends the review period of AstraZeneca (AZN)/Merck's filing seeking label expansion for...
Pharma Stock Roundup: LLY's 2023 View, MRK-MRNA Joint Cancer Vaccine Data & More
Zacks via Yahoo Finance· 1 year agoEli Lilly (LLY) gives its financial guidance for 2023. Merck (MRK) and Moderna's (MRNA) mRNA-based...
Pharma Stock Roundup: RHHBY's Alzheimer's Study Failure, EU Nod for SNY's Enjaymo
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) late-stage Alzheimer's disease study on key pipeline candidate, gantenerumab fails....
Pharma Stock Roundup: End of SNY's Amcenestrant Development, FDA Updates for AZN, GSK
Zacks via Yahoo Finance· 2 years agoSanofi (SNY) ends the development of breast cancer candidate, amcenestrant. Novartis' (NVS) lung...
Pharma Stock Roundup: PFE Gets Nod for RSV Vaccine, J&J Finalizes Kenvue Separation
Zacks via Yahoo Finance· 8 months agoFDA and EU approve Pfizer's (PFE) RSV vaccine, Abrysvo for maternal immunization. J&J (JNJ)...
Pharma Stock Roundup: FDA Okays PFE RSV Jab for Elderly, AZN Ends Brazikumab Studies
Zacks via Yahoo Finance· 11 months agoFDA approves Pfizer's (PFE) RSV vaccine for older adults and AstraZeneca (AZN) and Merck's (MRK)...
Prostate Cancer
Verywell Health via Yahoo News· 1 year agoProstate cancer is the most commonly diagnosed cancer in males, with risk factors including advanced age and a family history of the condition....